{"id":22382,"date":"2026-02-13T09:08:06","date_gmt":"2026-02-13T17:08:06","guid":{"rendered":"https:\/\/drugpolicy.ca\/68eme-session-de-la-commission-des-stupefiants-cnd68\/"},"modified":"2026-02-13T09:08:09","modified_gmt":"2026-02-13T17:08:09","slug":"68eme-session-de-la-commission-des-stupefiants-cnd68","status":"publish","type":"post","link":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/","title":{"rendered":"68\u00e8me session de la Commission des stup\u00e9fiants (CND68)"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong><em>Aborder l&#8217;impact des drogues synth\u00e9tiques sur les droits de l&#8217;homme : D\u00e9fis pour les groupes vuln\u00e9rables dans les Am\u00e9riques<\/em><\/strong> <\/h2>\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-1024x1024.jpeg\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-1024x1024.jpeg\" alt=\"\" class=\"wp-image-20310\" srcset=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-1024x1024.jpeg 1024w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-300x300.jpeg 300w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-150x150.jpeg 150w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-768x768.jpeg 768w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1-1536x1536.jpeg 1536w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Flyer-with-speakers-1.jpeg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\"><strong>\u00c9v\u00e9nement parall\u00e8le organis\u00e9 par le groupe de travail transfrontalier sur les drogues de synth\u00e8se<\/strong> <\/figcaption><\/figure>\n\n<p class=\"wp-block-paragraph\">Le groupe de travail transfrontalier sur les drogues de synth\u00e8se est une initiative de la soci\u00e9t\u00e9 civile convoqu\u00e9e par la Drug Policy Alliance (DPA) et le Washington Office on Latin America (WOLA) dans le but d&#8217;apporter aux d\u00e9cideurs des informations et des propositions politiques fond\u00e9es sur des donn\u00e9es scientifiques, la sant\u00e9, la compassion et les droits de l&#8217;homme en r\u00e9ponse \u00e0 la crise des overdoses de drogues de synth\u00e8se. Les d\u00e9cideurs et autres parties prenantes d\u00e9fendent des strat\u00e9gies cl\u00e9s et \u00e9vitent les paradigmes d\u00e9faillants et nuisibles.  <\/p>\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/youtu.be\/wbpgdGCc9yI\">Regardez les<\/a> moments forts de la session <a href=\"https:\/\/youtu.be\/wbpgdGCc9yI\">ici.<\/a><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Quand :<\/strong> Mardi<sup>11<\/sup> mars 2025  <\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Les participants<\/strong> <\/p>\n\n<ul start=\"1\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/youtu.be\/wbpgdGCc9yI\">John Walsh<\/a>, Bureau de Washington sur l&#8217;Am\u00e9rique latine (mod\u00e9rateur)  <\/li>\n<\/ul>\n\n<ul start=\"2\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/youtu.be\/wbpgdGCc9yI\">Steve Rolles<\/a>, Fondation Transform Drug Policy  <\/li>\n<\/ul>\n\n<ul start=\"3\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=wbpgdGCc9yI&amp;t=1342s\">Theshia Naidoo<\/a>, Alliance pour la politique des drogues  <\/li>\n<\/ul>\n\n<ul start=\"4\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=wbpgdGCc9yI&amp;t=1822s\">Lisa S\u00e1nchez<\/a>, M\u00e9xico Unido Contra la Delincuencia (Mexique contre la d\u00e9linquance)  <\/li>\n<\/ul>\n\n<ul start=\"5\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=wbpgdGCc9yI&amp;t=2648s\">Renata Demichelis<\/a>, Elementa DDHH  <\/li>\n<\/ul>\n\n<ul start=\"6\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=wbpgdGCc9yI&amp;t=917s\">Nick Boyce<\/a>, Politique canadienne en mati\u00e8re de drogues<a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/CDPC_CND-68-human-rights-side-event.pdf\">(voir les diapositives de la pr\u00e9sentation<\/a>)<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\"><strong><em>D\u00e9criminalisation des drogues : Distinguer la r\u00e9alit\u00e9 de la fiction<\/em><\/strong> <\/h2>\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1-1024x576.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1-1024x576.jpg\" alt=\"\" class=\"wp-image-20314\" srcset=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1-1024x576.jpg 1024w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1-300x169.jpg 300w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1-768x432.jpg 768w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1-1536x864.jpg 1536w, https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/05\/Decrim-Side-Event-Flyer-1.jpg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\"><strong>\u00c9v\u00e9nement parall\u00e8le organis\u00e9 par Dejusticia, Drug Policy Alliance, Release<\/strong> <\/figcaption><\/figure>\n\n<p class=\"wp-block-paragraph\">Les pr\u00e9judices caus\u00e9s et exacerb\u00e9s par les politiques en mati\u00e8re de drogues qui reposent sur la criminalisation et la punition sont bien document\u00e9s. En r\u00e9ponse, des juridictions du monde entier se sont tourn\u00e9es vers des strat\u00e9gies alternatives qui mettent l&#8217;accent sur la sant\u00e9 et les droits de l&#8217;homme, y compris plus de 70 r\u00e9gions nationales ou infranationales qui ont adopt\u00e9 diverses formes de d\u00e9criminalisation des drogues. Si certaines de ces politiques sont op\u00e9rationnelles depuis des d\u00e9cennies, d&#8217;autres r\u00e9formes, plus r\u00e9centes, se sont heurt\u00e9es \u00e0 des r\u00e9actions n\u00e9gatives et \u00e0 des revers. Cet \u00e9v\u00e9nement parall\u00e8le discutera des m\u00e9faits de la criminalisation, fournira des faits pour contrer la d\u00e9sinformation sur les politiques de drogues ax\u00e9es sur la sant\u00e9, et discutera des strat\u00e9gies employ\u00e9es et des le\u00e7ons tir\u00e9es des r\u00e9cents efforts de d\u00e9criminalisation.     <\/p>\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/youtu.be\/q-5hVzMhglw\">Regardez<\/a> la session <a href=\"https:\/\/youtu.be\/q-5hVzMhglw\">ici.<\/a> <\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Quand :<\/strong> Mercredi<sup>12<\/sup> mars 2025  <\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Pr\u00e9sident : <\/strong>Commission mondiale sur la politique des drogues  <\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Intervenants :<\/strong> <\/p>\n\n<ul class=\"wp-block-list\">\n<li>Theshia Naidoo Drug Policy Alliance, \u00c9tats-Unis  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Nick Boyce, Coalition canadienne des politiques sur les drogues <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Isabel Pereira-Arana, Dejusticia, Colombie  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Michael Kessler, Michael Kessler Media  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Daniel Joloy, Amnesty International  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Niamh Eastwood, Lib\u00e9ration, Royaume-Uni  <\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><strong>Coparrainants ONG :<\/strong> <\/p>\n\n<ul class=\"wp-block-list\">\n<li>Amnesty International  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Coalition canadienne des politiques sur les drogues  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>D\u00e9justice  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>D\u00e9sentir  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Drug Policy Alliance (Alliance pour la politique en mati\u00e8re de drogues)  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Centre international sur les droits de l&#8217;homme et la politique des drogues  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Consortium international pour la politique des drogues  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>INPUD  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>LANPUD  <\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>Lib\u00e9ration  <\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Aborder l&#8217;impact des drogues synth\u00e9tiques sur les droits de l&#8217;homme : D\u00e9fis pour les groupes vuln\u00e9rables dans les Am\u00e9riques Le groupe de travail transfrontalier sur les drogues de synth\u00e8se est une initiative de la soci\u00e9t\u00e9 civile convoqu\u00e9e par la Drug Policy Alliance (DPA) et le Washington Office on Latin America (WOLA) dans le but d&#8217;apporter [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":22378,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[33,7],"tags":[],"class_list":["post-22382","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-international-fr","category-non-classifiee"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>68\u00e8me session de la Commission des stup\u00e9fiants (CND68) - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"68\u00e8me session de la Commission des stup\u00e9fiants (CND68) - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Aborder l&#8217;impact des drogues synth\u00e9tiques sur les droits de l&#8217;homme : D\u00e9fis pour les groupes vuln\u00e9rables dans les Am\u00e9riques Le groupe de travail transfrontalier sur les drogues de synth\u00e8se est une initiative de la soci\u00e9t\u00e9 civile convoqu\u00e9e par la Drug Policy Alliance (DPA) et le Washington Office on Latin America (WOLA) dans le but d&#8217;apporter [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-13T17:08:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T17:08:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/backup.drugpolicy.ca\/wp-content\/uploads\/2025\/11\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"68\u00e8me session de la Commission des stup\u00e9fiants (CND68)\",\"datePublished\":\"2026-02-13T17:08:06+00:00\",\"dateModified\":\"2026-02-13T17:08:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/\"},\"wordCount\":504,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png\",\"articleSection\":[\"International\",\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/\",\"name\":\"68\u00e8me session de la Commission des stup\u00e9fiants (CND68) - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png\",\"datePublished\":\"2026-02-13T17:08:06+00:00\",\"dateModified\":\"2026-02-13T17:08:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/68eme-session-de-la-commission-des-stupefiants-cnd68\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"68\u00e8me session de la Commission des stup\u00e9fiants (CND68)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"68\u00e8me session de la Commission des stup\u00e9fiants (CND68) - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/","og_locale":"fr_FR","og_type":"article","og_title":"68\u00e8me session de la Commission des stup\u00e9fiants (CND68) - Canadian Drug Policy Coalition","og_description":"Aborder l&#8217;impact des drogues synth\u00e9tiques sur les droits de l&#8217;homme : D\u00e9fis pour les groupes vuln\u00e9rables dans les Am\u00e9riques Le groupe de travail transfrontalier sur les drogues de synth\u00e8se est une initiative de la soci\u00e9t\u00e9 civile convoqu\u00e9e par la Drug Policy Alliance (DPA) et le Washington Office on Latin America (WOLA) dans le but d&#8217;apporter [&hellip;]","og_url":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2026-02-13T17:08:06+00:00","article_modified_time":"2026-02-13T17:08:09+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/backup.drugpolicy.ca\/wp-content\/uploads\/2025\/11\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png","type":"image\/png"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#article","isPartOf":{"@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"68\u00e8me session de la Commission des stup\u00e9fiants (CND68)","datePublished":"2026-02-13T17:08:06+00:00","dateModified":"2026-02-13T17:08:09+00:00","mainEntityOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/"},"wordCount":504,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png","articleSection":["International","Non classifi\u00e9(e)"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/","url":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/","name":"68\u00e8me session de la Commission des stup\u00e9fiants (CND68) - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#primaryimage"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png","datePublished":"2026-02-13T17:08:06+00:00","dateModified":"2026-02-13T17:08:09+00:00","breadcrumb":{"@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#primaryimage","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2025\/11\/68th-Session-of-the-Commission-on-Narcotic-Drugs-CND68-blog-post-image.png","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/drugpolicy.ca\/fr\/68eme-session-de-la-commission-des-stupefiants-cnd68\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"68\u00e8me session de la Commission des stup\u00e9fiants (CND68)"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/22382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=22382"}],"version-history":[{"count":4,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/22382\/revisions"}],"predecessor-version":[{"id":22386,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/22382\/revisions\/22386"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/22378"}],"wp:attachment":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=22382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=22382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=22382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}